Chordoma Spontaneous Regression After COVID-19
Viruses · 2024
DOI: 10.3390/v17010010 ↗Kurz gefasst
Fallbericht in der Zeitschrift Viruses, 2024. Verfasst von Luis Fernando Moura da Silva Junior und 6 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital of UFMA, Federal University of Maranhao, São Luís 65080-805, Maranhão, Brazil. Hauptthemen laut MEDLINE: Chordoma, COVID-19, Neoplasm Regression, Spontaneous, Skull Base Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chordomas are a low-to-intermediate-grade slow-growing subtype of sarcoma, but show propensity to grow and invade locally with recurrence and metastasis in 10–40% of cases. We describe the first case of spontaneous regression of a solid tumor (histologically and immunohistochemically proven chordoma) after COVID-19. A female patient with clival chordoma underwent occipitocervical fixation prior to tumor resection. In the early post-operative stage following the arthrodesis procedure, she was diagnosed with COVID-19. Six months after COVID-19, she finally came back for endoscopic endonasal resection of the tumor and pre-operative MRI surprisingly showed 98.9% regression of the tumor volume. Tumor resection was performed, and both histopathological and immunohistochemistry confirmed diagnosis of chordoma with positive brachyury levels. She showed improvement of right hemiparesis and left-sided tongue palsy. The tumor was comprised of tumor-infiltrating inflammatory cells. CD3 and CD68 were positive, suggesting the presence of T-lymphocytes and macrophages. CD20 and CD56 were negative, suggesting the absence of B-lymphocytes and NK-cells. The authors believe that the onset of COVID-19 exacerbated the patient’s immune response and improved anti-tumor immunity. It was concluded that T-cells, which are involved in the COVID-19 immune response and were found infiltrating the tumor, acted as a critical pathway to this event. Further studies are encouraged in order to gain a better understanding of the SARS-CoV-2–chordoma interaction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University Hospital of UFMA, Federal University of Maranhao, São Luís 65080-805, Maranhão, Brazil.
- Duke Global Health Institute, Duke University, Durham, NC 27710, USA.
- Postgraduate Program in Genetics, Faculty of Medicine of Ribeirao Preto, University of São Paulo, Ribeirão Preto 14049-900, São Paulo, Brazil.
- Dr. Carlos Macieira Hospital, São Luís 65075-441, Maranhão, Brazil.
ORCID-Profile: Antonio Augusto Lima Teixeira Júnior
Zitieren
APA
Silva Junior, L. F. M. D., Silva, G. E. B., Campos, M. A. G., Teixeira Júnior, A. A. L., Santos, R. M., Santos, O. J. D., & Salgado Filho, N. (2024). Chordoma Spontaneous Regression After COVID-19. Viruses. https://doi.org/10.3390/v17010010
Vancouver
Silva Junior LFMD, Silva GEB, Campos MAG, Teixeira Júnior AAL, Santos RM, Santos OJD, et al. Chordoma Spontaneous Regression After COVID-19. Viruses. 2024. doi:10.3390/v17010010
BibTeX
@article{SilvaJunior2024,
author = {Silva Junior, Luis Fernando Moura da and Silva, Gyl Eanes Barros and Campos, Marcos Adriano Garcia and Teixeira Júnior, Antonio Augusto Lima and Santos, Ramon Moura and Santos, Orlando José Dos and Salgado Filho, Natalino},
title = {Chordoma Spontaneous Regression After COVID-19},
journal = {Viruses},
year = {2024},
doi = {10.3390/v17010010}
}
EUVIMED